IGM Biosciences Inc. (IGMS) Reports Q4 Loss of $0.79/sh
- S&P 500, Dow slip as focus turns to tech earnings
- Analysts Positive, Raise PTs as IBM (IBM) Tops Market Estimates and Reaffirms Guidance
- Boeing (BA) Down 3% After CFO - Aged 54 - Retires, Seen as an 'Odd' Move
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
IGM Biosciences Inc. (NASDAQ: IGMS) reported Q4 EPS of ($0.79), versus ($0.49) reported last year.
For earnings history and earnings-related data on IGM Biosciences Inc. (IGMS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Johnson & Johnson (JNJ) Tops Q1 EPS by 25c, Updates Guidance
- New Oriental Education (EDU) Tops Q3 EPS by 3c, Revenues Beat; Offers 4Q Revenue Guidance Above Consensus
- Lockheed Martin (LMT) Tops Q1 EPS by 26c, Updates Guidance